Circ_0003575 knockdown alleviates ox-LDL-induced human aortic endothelial cell dysfunction in atherosclerosis by

Zhanshuai Zhang1, Shaoqiang Qin1, Rui Wang1

  • 1Department of Cardiovascular Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei, China.

Abstract

Insights

Circular RNA circ_0003575 promotes atherosclerosis by damaging human aortic endothelial cells. Inhibiting circ_0003575 protects against this damage by regulating the miR-637/TRAF6 and NF-κB pathways.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) are implicated in atherosclerosis (AS) progression.
  • The specific role of circ_0003575 in AS pathogenesis requires elucidation.

Purpose of the Study:

  • To investigate the functional role and underlying mechanism of circ_0003575 in an in vitro model of atherosclerosis.
  • To determine the interaction between circ_0003575, microRNA-637 (miR-637), and TNF receptor associated factor 6 (TRAF6) in endothelial cells.

Main Methods:

  • Established an atherosclerosis cell model using oxidized low-density lipoprotein (ox-LDL) treated human aortic endothelial cells (HAECs).
  • Assessed cell proliferation (CCK-8, EdU), apoptosis (flow cytometry), angiogenesis (tube formation assay), and inflammatory factor release (ELISA).
  • Quantified gene and protein expression (qRT-PCR, Western blot) and investigated molecular interactions (dual-luciferase, RIP assays).

Main Results:

  • Ox-LDL induced endothelial cell injury, characterized by reduced proliferation and angiogenesis, and increased apoptosis and inflammation.
  • Knockdown of circ_0003575 significantly ameliorated ox-LDL-induced HAEC damage.
  • Circ_0003575 directly targeted miR-637, which in turn targeted TRAF6. MiR-637 overexpression mimicked the protective effects of circ_0003575 knockdown.
  • Circ_0003575 silencing inhibited the NF-κB signaling pathway activation.

Conclusions:

  • Circ_0003575 knockdown exerts protective effects against ox-LDL-induced human aortic endothelial cell injury.
  • The mechanism involves the regulation of the miR-637/TRAF6 axis and the NF-κB pathway.
  • Circ_0003575 represents a potential therapeutic target for atherosclerosis.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K